선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Willis Towers Watson Public Limited Company's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $26.8B | |
|---|---|---|
| P/E (forward) | 17.4x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $8.83B | $8.73B | $9.30B | $9.74B | $9.52B | +1.9% |
| Gross profit | $3.75B | $3.80B | $7.67B | $4.43B | $4.08B | +2.2% |
| Operating income | $2.20B | $1.18B | $1.37B | $627.0M | $2.23B | +0.4% |
| Net income | $4.22B | $1.01B | $1.06B | $-98.0M | $1.61B | -21.5% |
| EPS (diluted) | $32.78 | $8.98 | $9.95 | $-0.96 | $16.26 | -16.1% |
| EBITDA | $3.55B | $2.03B | $1.37B | $823.0M | $2.68B | -6.9% |
| R&D | $0 | $0 | $0 | — | — | -34.2% |
| SG&A | $6.93B | $6.84B | — | — | — | -1.2% |
Recent company headlines from major financial publishers.
The modal base case path reflects steady mid-single-digit organic growth supported by recurring corporate benefits administration in Health, Wealth & Career and balanced international commercial placement. The Propel restructuring program steadily scales operating margins over the transformation horizon, while disciplined annual share repurchases compound per-share cash flow, supporting the composite fair value midpoint.
Under the upside scenario, the $625M Propel restructuring program rapidly eliminates administrative bottlenecks, enabling brokers and consultants to win competitive market share from peers. Enterprise adjusted operating margins reach 30.0% by FY2028, supported by 35% in Health, Wealth & Career and 30% in Risk & Broking. Accelerated free cash flow expansion finances heavy share repurchases, compounding diluted EPS toward the top of our valuation range.
| Ke ↓ / g → | 2.3% | 2.5% | 2.8% | 3.0% | 3.3% |
|---|---|---|---|---|---|
| 6.5% | $470 | $487 | $507 | $531 | $559 |
| 7.0% | $435 | $447 | $462 | $479 | $498 |
| 7.5% | $406 | $416 | $427 | $440 | $454 |
| 8.0% | $383 | $391 | $400 | $409 | $420 |
| 8.5% | $364 | $370 | $377 | $385 | $393 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |